Literature DB >> 21835230

An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen-Hao-Tang based on its active constituents.

Aihua Zhang1, Hui Sun, Ye Yuan, Wenjun Sun, Guozheng Jiao, Xijun Wang.   

Abstract

6,7-Dimethylesculetin (D), geniposide (G) and rhein (R) are the three major active ingredients of Yin-Chen-Hao-Tang (YCHT), a famous Chinese herbal formula, which has been shown to be clinically effective for treating hepatic injury (HI) syndrome. The present study was conducted to investigate the therapeutic and synergistic effects of COC (combination of D, G and R) on HI rats by combining pharmacokinetic with biochemical analysis strategy. Plasma was analyzed by using reversed-phase high performance liquid chromatography (RP-HPLC). Principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA) models were built to evaluate the therapeutic and synergistic effects of COC at the biochemical level. Here, we report that the COC combination could increase the plasma level, slow elimination rate, exert a more robust therapeutic effect than any one or two of the three individual compounds by hitting multiple targets in a rat model of HI. Overall, this beneficially accounts for the popular view that traditional Chinese medicine (TCM) formula usually takes multi-component to exert their therapeutic effects. We suggest that dissecting the mode of action of clinically effective formula to be capable of producing a sufficient effect at low doses.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835230     DOI: 10.1016/j.fitote.2011.07.014

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  33 in total

Review 1.  Future perspectives of Chinese medical formulae: chinmedomics as an effector.

Authors:  Xijun Wang; Aihua Zhang; Hui Sun
Journal:  OMICS       Date:  2012-06-26

Review 2.  The Beneficial Effects of Geniposide on Glucose and Lipid Metabolism: A Review.

Authors:  Siting Gao; Qin Feng
Journal:  Drug Des Devel Ther       Date:  2022-09-30       Impact factor: 4.319

3.  High-throughput liquid chromatography mass-spectrometry-driven lipidomics discover metabolic biomarkers and pathways as promising targets to reveal the therapeutic effects of the Shenqi pill.

Authors:  Wen-Xiu Li; Ai-Hua Zhang; Xiao-Hang Zhou; Yang Nan; Qi Liu; Hui Sun; Heng Fang; Xi-Jun Wang
Journal:  RSC Adv       Date:  2020-01-13       Impact factor: 4.036

4.  Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies.

Authors:  Xijun Wang; Aihua Zhang; Ping Wang; Hui Sun; Gelin Wu; Wenjun Sun; Haitao Lv; Guozheng Jiao; Hongying Xu; Ye Yuan; Lian Liu; Dixin Zou; Zeming Wu; Ying Han; Guangli Yan; Wei Dong; Fangfang Wu; Tianwei Dong; Yang Yu; Shuxiang Zhang; Xiuhong Wu; Xin Tong; Xiangcai Meng
Journal:  Mol Cell Proteomics       Date:  2013-01-29       Impact factor: 5.911

5.  Proteomics analysis of hepatoprotective effects for scoparone using MALDI-TOF/TOF mass spectrometry with bioinformatics.

Authors:  Aihua Zhang; Hui Sun; Gelin Wu; Wenjun Sun; Ye Yuan; Xijun Wang
Journal:  OMICS       Date:  2013-03-20

6.  A Novel Pharmacological Method to Study the Chinese Medicinal Formula Hua-Zheng-Hui-Sheng-Dan.

Authors:  Rui Cao; Hong Zhang; Jie Guo; Xiao-Hui Liu; Chang Liu; Cui-Hong Zhu; Xiong-Zhi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2015-09-01       Impact factor: 2.629

Review 7.  Evaluation of the target-specific therapeutic potential of herbal compounds for the treatment of cancer.

Authors:  Shobha Upreti; Satish Chandra Pandey; Ila Bisht; Mukesh Samant
Journal:  Mol Divers       Date:  2021-07-08       Impact factor: 2.943

8.  UPLC Q-TOF/MS-Based Metabolic Profiling of Urine Reveals the Novel Antipyretic Mechanisms of Qingkailing Injection in a Rat Model of Yeast-Induced Pyrexia.

Authors:  Xiaoyan Gao; Mingxing Guo; Long Peng; Baosheng Zhao; Jiankun Su; Haiyu Liu; Li Zhang; Xu Bai; Yanjiang Qiao
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-06       Impact factor: 2.629

9.  Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for a randomized, double-blind, placebo-controlled trial.

Authors:  Lun-Chien Lo; Chia-Yun Chen; Shou-Tung Chen; Hung-Chang Chen; Tsung-Chieh Lee; Cheng-Shyong Chang
Journal:  Trials       Date:  2012-12-03       Impact factor: 2.279

10.  Metabolomics and proteomics annotate therapeutic properties of geniposide: targeting and regulating multiple perturbed pathways.

Authors:  Xijun Wang; Aihua Zhang; Guangli Yan; Wenjun Sun; Ying Han; Hui Sun
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.